Home > Result Summaries: Compounds > naratriptan > Result Summary for S2W30018

Result Summary for S2W30018

Result Summary

Protocol ID:	S2W30018
Clinical Study ID:	S2W30018
Official Title:	An open study of the efficacy and tolerability of naratriptan in prophylactic treatment of pure menstrual migraine attacks.
Phase:	Phase 3
Study Indications or Diseases:	Migraine Disorders and Premenstrual Syndrome
Generic Name:	naratriptan
Trade/Product Name:	amerge;naramig
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Moschiano F, Allais G, Grazzi L, Usai S, Benedetto C, D'Amico D, Roncolato M, Bussone G. Naratriptan in the short-term prophylaxis of pure menstrual migraine. Neurol Sci. 2005; 26 Suppl 2:s162-6.